Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | PKM | P14618 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16705159 | 1.00 | KDM4E (0.35) | KDM4ELMNAALDH1A1MEN1HTT | |
| SCHEMBL16704800 | 1.00 | KDM4E (0.35) | KDM4ELMNAALDH1A1MEN1HTT | |
| SCHEMBL2020308 | 0.83 | — | — | |
| SCHEMBL9317589 | 0.81 | KDM4E (0.38) | KDM4ELMNAALDH1A1EPHX2TDP1 | |
| SCHEMBL21594539 | 0.79 | KDM4E (0.36) | KDM4ELMNAALDH1A1MEN1HTT | |
| SCHEMBL21215002 | 0.77 | KDM4E (0.35) | KDM4ELMNAALDH1A1EPHX2TDP1 | |
| SCHEMBL4545263 | 0.77 | KDM4E (0.39) | KDM4ELMNAALDH1A1EPHX2TDP1 | |
| SCHEMBL2458229 | 0.77 | KDM4E (0.35) | KDM4ELMNAALDH1A1MEN1KMT2A | |
| SCHEMBL2016534 | 0.76 | KDM4E (0.34) | KDM4ELMNAALDH1A1EPHX2PKM | |
| SCHEMBL2016537 | 0.76 | KDM4E (0.38) | KDM4ELMNAALDH1A1EPHX2TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2016141563-A1 | ALICYCLIC EPOXIDE AND PREPARATION METHOD THEREFOR, AND METHOD FOR PREPARING 2-HYDROXYL-4-OXA-5-THIA TRICYCLE[4.2.1.03,7] NONANE DERIVATIVE | 株式会社大赛璐 | 2016-09-15 | — | — | WO | disclosed |
| US-9170487-B2 | Resist composition, method of forming resist pattern, and polymeric compound | TOKYO OHKA KOGYO CO., LTD. (JP) | 2015-10-27 | — | — | US | disclosed |
| US-9152042-B2 | Acrylic ester derivative, high-molecular compound and photoresist composition | KURARAY CO., LTD. (JP) | 2015-10-06 | — | — | US | disclosed |
| US-20130260312-A1 | RESIST COMPOSITION, METHOD OF FORMING RESIST PATTERN, AND POLYMERIC COMPOUND | TOKYO OHKA KOGYO CO., LTD. (JP) | 2013-10-03 | — | — | US | disclosed |
| US-20130230802-A1 | ACRYLAMIDE DERIVATIVE, POLYMER COMPOUND AND PHOTORESIST COMPOSITION | KURARAY CO., LTD. (JP) | 2013-09-05 | — | — | US | disclosed |
| US-20130164675-A1 | ACRYLIC ESTER DERIVATIVE, HIGH-MOLECULAR COMPOUND AND PHOTORESIST COMPOSITION | KURARAY CO., LTD. (JP) | 2013-06-27 | — | — | US | disclosed |
| US-8367849-B2 | Production method for sultone derivatives | KURARAY CO., LTD. (JP) | 2013-02-05 | — | — | US | disclosed |
| US-8367849-B2 | Production method for sultone derivatives | KURARAY CO., LTD. (JP) | 2013-02-05 | — | — | US | disclosed |
| US-8367849-B2 | Production method for sultone derivatives | KURARAY CO., LTD. (JP) | 2013-02-05 | — | — | US | disclosed |
| US-20110160465-A1 | PRODUCTION METHOD FOR SULTONE DERIVATIVES | KURARAY CO., LTD (JP) | 2011-06-30 | — | — | US | disclosed |
| US-20110160465-A1 | PRODUCTION METHOD FOR SULTONE DERIVATIVES | KURARAY CO., LTD (JP) | 2011-06-30 | — | — | US | disclosed |
| US-20110160465-A1 | PRODUCTION METHOD FOR SULTONE DERIVATIVES | KURARAY CO., LTD (JP) | 2011-06-30 | — | — | US | disclosed |
| US-4017669-A | COORDINATION CATALYST | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1977-04-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110160465-A1 | PRODUCTION METHOD FOR SULTONE DERIVATIVES | SULT1E1, SULT2A1, SULT1A1 | KDM4E 1041/4885LMNA 4818/4885ALDH1A1 45/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.